BAKER BROS. ADVISORS LP – Aerovate Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$32.82M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+6.08%
quarter
Aerovate Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.37% | -90.44K shares | 467K | $16.58 | 1.97M |
| Q2 2022 | share | 0.00% | 0 shares | -5.58M | $15.63 | 2.07M | |
| Q1 2022 | share | Increase | +13.00% | 238.22K shares | 16.34M | $18.33 | 2.07M |
| Q4 2021 | share | Increase | +10.87% | 179.61K shares | -13.06M | $11.19 | 1.83M |
| Q3 2021 | share | Increase | +15.65% | 223.6K shares | 2.04M | $20.98 | 1.65M |
| Q2 2021 | share | Increase | 0.00% | 1.42M shares | 32.61M | $22.83 | 1.42M |